Overview
and Scope
Anaphylaxis treatment refers to the treatment of life-threatening allergic
reactions to foods, insect stings, medications, and latex in which immediate
administration of epinephrine is given to reverse the allergic reaction and
stabilize the patient’s condition. Rapid medical treatment and comprehensive
supportive care are required to effectively manage potentially life-threatening
symptoms of anaphylaxis.
Sizing and Forecast
The anaphylaxis treatment market size has grown strongly in recent years. It
will grow from $5.73 billion in 2023 to $6.15 billion in 2024 at a compound
annual growth rate (CAGR) of 7.3%.
The growth in the historic period
can be attributed to increasing incidence of allergic reactions, wider
recognition of anaphylaxis, increased availability of epinephrine
auto-injectors, public awareness and education, healthcare professional
training.
The anaphylaxis treatment market size is expected to see strong growth in the
next few years. It will grow to $7.97 billion in 2028 at a compound annual
growth rate (CAGR) of 6.7%. The growth
in the forecast period can be attributed to innovation in biologic therapies,
customized treatment approaches, global efforts on food safety, patient empowerment
and advocacy, enhanced emergency medical services. Major trends in the forecast
period include auto-injectors innovation, telemedicine for anaphylaxis
management, improved allergen immunotherapy, biometric wearables for allergen
detection, collaborations in allergy research.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Segmentation & Regional Insights
The anaphylaxis treatment market covered in this report is segmented –
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other
Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other
Applications
North America was the largest region in the anaphylaxis treatment market in
2023. Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the anaphylaxis treatment market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of food allergies is expected to propel the growth
of the anaphylaxis treatment market going forward. Food allergy refers to an
immune reaction to proteins in food. Anaphylaxis treatment helps to prevent the
progression of life-threatening allergic symptoms involving the skin, mucosal
surface, respiratory compromise, hypotension, and end-organ dysfunction. For
instance, in January 2023, according to the Centers for Disease Control and
Prevention, a US-based government agency, in 2021, 31.8% of adults aged 18 and
older reported having eczema, a seasonal allergy, or a food allergy. One-fourth
(25.7%) of adults had a seasonal allergy, 6.2% had a food allergy, and 7.3% of
individuals had eczema. Therefore, the rise in the prevalence of food allergies
is driving the growth of the anaphylaxis treatment market.
Key Industry Players
Major companies operating in the anaphylaxis treatment market report are Pfizer
Inc., Merck & Co. Inc., Novartis International AG, Abbott Laboratories,
GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd.,
Regeneron Pharmaceuticals Inc., Mylan N.V., Bausch Health Companies, Sun
Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma
Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar
Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., MannKind
Corporation, Meridian Medical Technologies LLC, Aquestive Therapeutics Inc.,
Sandoz Inc., Bioprojet SCR, Adamis Pharmaceutical Corporation, Impax
Laboratories LLC.
The anaphylaxis treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional
And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future
Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment